G1 Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
G1 Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • G1 Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $184M, a 5.68% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $184M +$9.87M +5.68% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $174M +$36.5M +26.5% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $137M +$27.6M +25.2% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $110M +$23.8M +27.7% Dec 31, 2020 10-K 2022-02-23
Q4 2019 $86M +$29.5M +52.2% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $56.5M +$26.6M +89% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $29.9M +$8.98M +42.9% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $20.9M Dec 31, 2016 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.